Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 228 member A (FAM228A) is a poorly characterized human protein encoded by the FAM228A gene (HGNC:34418, UniProt Q86W67), previously known as C2orf84[3][1]. Its predicted amino acid sequence comprises 206 residues, with expression detected in brain and testis in mouse orthologs[4]. FAM228A does not belong to well-recognized molecular classes like receptors, enzymes, or transcription factors, and no biological function has yet been attributed to the protein in published molecular or cellular studies. Current data only link FAM228A to Sotos syndrome via certain genetic studies, but no mechanistic relationship has been determined[3]. There are no known drugs, biomarkers, or safety issues associated with FAM228A, and it is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 228 member A (FAM228A).